58
Views
0
CrossRef citations to date
0
Altmetric
Review

Orbital vascular lesions: a review of clinical and imaging findings

, &
Pages 151-166 | Published online: 09 Jan 2014

References

  • Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconstr. Surg. 69(3), 412–422 (1982).
  • Leblanc GG, Golanov E, Awad IA, Young WL; Biology of Vascular Malformations of the Brain NINDS Workshop Collaborators. Biology of vascular malformations of the brain. Stroke 40(12), e694–e702 (2009).
  • Hayreh SS. Orbital vascular anatomy. Eye (Lond.) 20(10), 1130–1144 (2006).
  • Lasjaunias P, Berenstein A, TerBrugge KG. Embryology and anatomy of the branches supplying the orbit. In: Surgical Neuroangiography. Vol. 1: Clinical Vascular Anatomy and Variations (2nd Edition). Springer-Verlag, Berlin, Germany 426–455 (2001).
  • Alvarez H, Rodesch G, Garcia-Monaco R, Lasjaunias P. Embolisation of the ophthalmic artery branches distal to its visual supply. Surg. Radiol. Anat. 12(4), 293–297 (1990).
  • Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8(6), 464–478 (2007).
  • Harris GJ. Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital Society. Am. J. Ophthalmol. 127(4), 453–455 (1999).
  • Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum. Mol. Genet. 16(Spec. No. 2), R140–R149 (2007).
  • Wiegand S, Eivazi B, Barth PJ et al. Pathogenesis of lymphangiomas. Virchows Arch. 453(1), 1–8 (2008).
  • Wilting J, Papoutsi M, Christ B et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J. 16(10), 1271–1273 (2002).
  • Brouillard P, Vikkula M. Vascular malformations: localized defects in vascular morphogenesis. Clin. Genet. 63(5), 340–351 (2003).
  • Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast. Reconstr. Surg. 115(1), 22–30 (2005).
  • Bisdorff A, Mulliken JB, Carrico J, Robertson RL, Burrows PE. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR. Am. J. Neuroradiol. 28(2), 335–341 (2007).
  • Killer HE, Laeng HR, Groscurth P. Lymphatic capillaries in the meninges of the human optic nerve. J. Neuroophthalmol. 19(4), 222–228 (1999).
  • Dickinson AJ, Gausas RE. Orbital lymphatics: do they exist? Eye (Lond.) 20(10), 1145–1148 (2006).
  • Lasjaunias P, TerBrugge K, Berenstein A. Surgical Neuroangiography. Vol. 3: Clinical and Interventional Aspects in Children (2nd Edition). Springer-Verlag, Berlin, Germany (2006).
  • Yoon JS, Choi JB, Kim SJ, Lee SY. Intralesional injection of OK-432 for vision-threatening orbital lymphangioma. Graefes Arch. Clin. Exp. Ophthalmol. 245(7), 1031–1035 (2007).
  • Dompmartin A,Vikkula M, Boon LM. Venous malformation: update on ethiopathogenesis, diagnosis and management. Phebology 25(5), 224–235 (2010).
  • Enjoras O, Wassef M, Chapot R. Vascular malformations. In: Color Atlas of Vascular Tumors and Vascular Malformations. Cambridge University Press, Cambridge, UK, 168–175 (2007).
  • Tuncer S, Peksayar G, Tefekli EG, Ayranci O, Demirci H. Multiple orbital venous malformations presenting with enophthalmos in a patient with presumed blue rubber bleb nevus syndrome. Ophthal. Plast. Reconstr. Surg. 24(4), 331–334 (2008).
  • Boukobza M, Enjolras O, Guichard JP et al. Cerebral developmental venous anomalies associated with head and neck venous malformations. AJNR. Am. J. Neuroradiol. 17(5), 987–994 (1996).
  • Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr. Surg. Int. 19(12), 766–773 (2004).
  • Spence J, Krings T, TerBrugge KG, Agid R. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck 33(1), 125–130 (2011).
  • Sainsbury DC, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast. Reconstr. Surg. 127(5), 2031–2044 (2011).
  • Ernemann U, Westendorff C, Troitzsch D, Hoffmann J. Navigation-assisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations. AJNR. Am. J. Neuroradiol. 25(10), 1792–1795 (2004).
  • Garcia DD, Heran MK, Amadi AJ, Rootman J. Low outflow distensible venous malformations of the anterior orbit: presentation, hemodynamic factors, and management. Ophthal. Plast. Reconstr. Surg. 27(1), 38–43 (2011).
  • Gigantelli JW, Gagnon MR, Arthur JA, Leopold DA. Endoscopic transethmoidal decompression of a thrombosed orbital venous malformation. Ear Nose Throat J. 81(5), 346–8, 351 (2002).
  • Lacey B, Rootman J, Marotta TR. Distensible venous malformations of the orbit: clinical and hemodynamic features and a new technique of management. Ophthalmology 106(6), 1197–1209 (1999).
  • Eskandari MR, Rahimi-Ardabili B, Javadzade A. Racemose hemangioma type 2: the first case report from the Middle East. Int. Ophthalmol. 33(1), 95–97 (2013).
  • Schmidt D, Pache M, Schumacher M. The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature. Surv. Ophthalmol. 53(3), 227–249 (2008).
  • Federici T, Batlle I. Periocular triamcinolone acetonide as treatment for macular edema secondary to branch vein occlusion associated with retinal arteriovenous malformation. Retina (Philadelphia, PA) 26(9), 1079–1080 (2006).
  • Muragaki Y, Ujiie H, Ohno M, Kubo O, Hori T. Optic nerve arteriovenous malformation causing optic apoplexy: case report. Neurosurgery 51(4), 1075–1078 (2002).
  • Bhattacharya JJ, Luo CB, Suh DC, Alvarez H, Rodesch G, Lasjaunias P. Wyburn-Mason or Bonnet–Dechaume–Blanc as cerebrofacial arteriovenous metameric syndromes (CAMS). A new concept and a new classification. Interv. Neuroradiol. 7(1), 5–17 (2001).
  • Dayani PN, Sadun AA. A case report of Wyburn-Mason syndrome and review of the literature. Neuroradiology 49(5), 445–456 (2007).
  • Wyburn-Mason R. Arteriovenous aneurysm of mid-brain and retina, facial nevi and mental changes. Brain 66, 163–190 (1943).
  • Le Douarin NM, Catala M, Batini C. Embryonic neural chimeras in the study of vertebrate brain and head development. Int. Rev. Cytol. 175, 241–309 (1997).
  • Couly G, Coltey P, Eichmann A, Le Douarin NM. The angiogenic potentials of the cephalic mesoderm and the origin of brain and head blood vessels. Mech. Dev. 53(1), 97–112 (1995).
  • Krings T, Geibprasert S, Luo CB, Bhattacharya JJ, Alvarez H, Lasjaunias P. Segmental neurovascular syndromes in children. Neuroimaging Clin. N. Am. 17(2), 245–258 (2007).
  • Gil-Salú JL, González-Darder JM, Vera-Román JM. Intraorbital arteriovenous malformation: case report. Skull Base 14(1), 31–36; discussion 36 (2004).
  • Warrier S, Prabhakaran VC, Valenzuela A, Sullivan TJ, Davis G, Selva D. Orbital arteriovenous malformations. Arch. Ophthalmol. 126(12), 1669–1675 (2008).
  • Matsumaru Y, Alvarez H, Rodesch G, Lasjaunias PL. Embolisation of branches of the ophthalmic artery. Interv. Neuroradiol. 3(3), 239–245 (1997).
  • Caragine LP Jr, Halbach VV, Dowd CF, Higashida RT. Intraorbital arteriovenous fistulae of the ophthalmic veins treated by transvenous endovascular occlusion: technical case report. Neurosurgery 58(1 Suppl.), ONS-E170; discussion (2006).
  • Hamada J, Morioka M, Kai Y, Sakurama T, Kuratsu J. Spontaneous arteriovenous fistula of the orbit: case report. Surg. Neurol. 65(1), 55–57; discussion 57 (2006).
  • Lin CJ, Blanc R, Clarençon F et al. Transvenous embolization of an intraorbital arteriovenous fistula using Onyx. J. Clin. Neurosci. 17(6), 783–785 (2010).
  • Cheng KC, Chang CH, Lin WC. Spontaneous resolution of intraorbital arteriovenous fistulas. Ophthal. Plast. Reconstr. Surg. 25(3), 245–247 (2009).
  • van den Berg R, Smagge LE, Saeed P, Majoie CB. Dural arteriovenous fistula of the optic nerve sheath. Orbit 28(6), 417–419 (2009).
  • Deguchi J, Yamada M, Ogawa R, Kuroiwa T. Transvenous embolization for a purely intraorbital arteriovenous fistula. Case report. J. Neurosurg. 103(4), 756–759 (2005).
  • Agid R, Terbrugge K, Rodesch G, Andersson T, Söderman M. Management strategies for anterior cranial fossa (ethmoidal) dural arteriovenous fistulas with an emphasis on endovascular treatment. J. Neurosurg. 110(1), 79–84 (2009).
  • Piché SL, Haw CS, Redekop GJ, Heran MK. Rare intracanalicular ophthalmic aneurysm: endovascular treatment and review of the literature. AJNR. Am. J. Neuroradiol. 26(8), 1929–1931 (2005).
  • Pandey P, Rayes M, Guthikonda M, Xavier A. Peripheral ophthalmic artery aneurysm associated with multiple intracranial aneurysms: a case report. J. Neurointerv. Surg. 2(3), 211–212 (2010).
  • Qiao L, Wang H, Mao L, Chen S, Xie W, Wu Q. Peripheral ophthalmic artery aneurysm. Neurosurg. Rev. 34(1), 29–38 (2011).
  • Ellis JA, Goldstein H, Connolly ES Jr, Meyers PM. Carotid-cavernous fistulas. Neurosurg. Focus 32(5), E9 (2012).
  • Gemmete JJ, Ansari SA, Gandhi DM. Endovascular techniques for treatment of carotid-cavernous fistula. J. Neuroophthalmol. 29(1), 62–71 (2009).
  • Zaidat OO, Lazzaro MA, Niu T et al. Multimodal endovascular therapy of traumatic and spontaneous carotid cavernous fistula using coils, n-BCA, Onyx and stent graft. J. Neurointerv. Surg. 3(3), 255–262 (2011).
  • Nadarajah M, Power M, Barry B, Wenderoth J. Treatment of a traumatic carotid-cavernous fistula by the sole use of a flow diverting stent. J. Neurointerv. Surg. 4(3), e1 (2012).
  • Bhatia KD, Wang L, Parkinson RJ, Wenderoth JD. Successful treatment of six cases of indirect carotid-cavernous fistula with ethylene vinyl alcohol copolymer (Onyx) transvenous embolization. J. Neuroophthalmol. 29(1), 3–8 (2009).
  • North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum. Pathol. 31(1), 11–22 (2000).
  • Enjolras O, Wassef M, Chapot R. Infantile hemangioma. In: Vascular Tumors and Vascular Malformations. Cambridge University Press, Cambridge, UK, 21–77 (2007).
  • Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch. Dermatol. 139(7), 869–875 (2003).
  • Jockin YM, Friedlander SF. Periocular infantile hemangioma. Int. Ophthalmol. Clin. 50(4), 15–25 (2010).
  • Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N. Engl. J. Med. 358(24), 2649–2651 (2008).
  • Blatt J, Morrell DS, Buck S et al. β-blockers for infantile hemangiomas: a single-institution experience. Clin. Pediatr. (Phila.) 50(8), 757–763 (2011).
  • Roach EE, Chakrabarti R, Park NI et al. Intrinsic regulation of hemangioma involution by platelet-derived growth factor. Cell Death Dis. 3, e328 (2012).
  • Christou E, Parsi K. Non-involuting congenital haemangioma of the eyelid: successful treatment with fluroscopic ultrasound guided sclerotherapy and surgical excision. Phlebology doi:10.1038/bjc.2012.381 (2012) (Epub ahead of print).
  • Fadell MF 2nd, Jones BV, Adams DM. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH). Pediatr. Radiol. 41(8), 1057–1060 (2011).
  • Berenguer B, Mulliken JB, Enjolras O et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr. Dev. Pathol. 6(6), 495–510 (2003).
  • Zywicke H, Palmer CA, Vaphiades MS, Riley KO. Optic nerve hemangioblastoma: a case report. Case Rep. Pathol. 2012, 915408 (2012).
  • Maher ER, Neumann HP, Richard S. von Hippel–Lindau disease: a clinical and scientific review. Eur. J. Hum. Genet. 19(6), 617–623 (2011).
  • Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond.) 27(2), 208–216 (2012).
  • Heimann H, Damato B. Congenital vascular malformations of the retina and choroid. Eye (Lond.) 24(3), 459–467 (2010).
  • Wiegand S, Zimmermann AP, Eivazi B et al. Analysis of clinically suspected orbital cavernomas. Br. J. Ophthalmol. 94(12), 1653–1656 (2010).
  • Hejazi N, Classen R, Hassler W. Orbital and cerebral cavernomas: comparison of clinical, neuroimaging, and neuropathological features. Neurosurg. Rev. 22, 28–33 (1999).
  • Smoker WR, Gentry LR, Yee NK, Reede DL, Nerad JA. Vascular lesions of the orbit: more than meets the eye. Radiographics 28(1), 185–204; quiz 325 (2008).
  • Limaiem R, Limaiem F, Kourda N, Zairi I, Chaabouni A, El Matri L. Primary orbital hemangiopericytoma: an unusual cause of unilateral proptosis. Can. J. Neurol. Sci. 37(2), 279–282 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.